This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Juno Therapeutics Gmbh. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Inventor Kien Khuu-Duong: Innovating Cell Composition Assessment
Introduction
Kien Khuu-Duong is an innovative inventor based in Snoqualmie, WA, USA. With a keen focus on the field of cellular analysis, Kien has made notable contributions to the assessment of particles within cell compositions. His work has important implications for research and therapeutic applications.
Latest Patents
Kien holds a patent for "Methods of enumerating particles present in a cell composition." This patent covers methods for assessing the presence or absence of particles, such as bead particles, in a cell composition. Furthermore, it includes articles of manufacture and kits designed for use in these methods, reflecting Kien's dedication to advancing scientific understanding and technology in the field.
Career Highlights
Kien is currently employed at Juno Therapeutics GmbH, a prominent company focusing on cellular therapy. His work contributes to the innovative approaches that Juno Therapeutics uses to develop advanced treatments for diseases. Kien's patent stands as a testimony to his expertise and commitment to improving methodologies in the field of cell analysis.
Collaborations
During his career, Kien has collaborated with esteemed colleagues, including Calvin Chan and Rachel K. Yost. Their collective efforts not only enhance the effectiveness of their work but also foster a spirit of innovation and teamwork within their professional environment.
Conclusion
Kien Khuu-Duong exemplifies the impact that dedicated inventors can have on scientific advancement. His patented methods for enumerating particles in cell compositions promise to revolutionize techniques in cellular analysis. With a strong foundation at Juno Therapeutics and collaboration with talented coworkers, Kien continues to contribute to the frontier of biomedical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
